Medison to market flagship scanner

Article

The Food and Drug Administration has put the final regulatory pieces together for South Koreanultrasound vendor Medison. After a rather prolonged wait, theagency cleared Medison's SonoAce 4800 scanner, a gray-scale Dopplersystem that will be Medison's

The Food and Drug Administration has put the final regulatory pieces together for South Koreanultrasound vendor Medison. After a rather prolonged wait, theagency cleared Medison's SonoAce 4800 scanner, a gray-scale Dopplersystem that will be Medison's premium scanner until the introductionof a color-flow Doppler unit some time in the future, accordingto Mark Hayward, president of Medison's U.S. subsidiary in Pleasanton,CA. Two other Medison systems were cleared last year, with SonoAce4800 the last of the vendor's scanners in the FDA's review process(SCAN 2/2/94).

SonoAce 4800 is a convex, linear, mechanical and pulsed Dopplersystem that will be targeted at vascular and abdominal applications.Medison will handle direct sales and will market the system primarilyto the in-office ultrasound market. List price of SonoAce 4800with Doppler, two probes and a printer is $38,900. Medison marketsa color-flow Doppler unit in Korea and plans to bring that scannerto the U.S., Hayward said.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.